Study Supports PSA Screening for Male BRCA2 Carriers
Further follow-up needed to assess benefit of PSA screening in male BRCA1 mutation carriers.
Diagnosis & Disease Information
USPSTF Expands Criteria for Recommended BRCA-Associated Genetic Counseling
A closer look at the USPSTF’s recent update to its recommendations for risk assessment, genetic counseling, and genetic testing for BRCA1/2-related cancers.
BRCA Mutations May Indicate Increased Cancer Risk in Men
Men with BRCA mutations may be at increased risk of several different types of cancer.
Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
The US FDA has approved a consumer test that may indicate increased breast and ovarian cancer risk in some individuals.
BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Results from the POSH breast cancer study may influence decisions regarding treatments intended to reduce the incidence of second primary cancers in patients with BRCA-positive triple-negative breast cancer.
MDS, AML a Risk With PARP Inhibitors in BRCA Mutation Carriers
What is the concern behind PARP inhibitors and leukemia?
Counseling Regarding Genetic Testing in Breast Cancer Lacking, Yet Many Still Undergo BLM
Many women with breast cancer with genetic VUS undergo testing and bilateral mastectomy (BLM) without ever receiving genetic counseling.
Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
Risk assessment study for carriers of the BRCA1/2 mutation identified the factors that influence their risk of developing breast cancer, ovarian cancer, or contralateral breast cancer.
Novel Approach Increases Breast, Ovarian Cancer Genetic Screening
A questionnaire added to intake forms at a breast cancer imaging center identified women with BRCA mutations who might otherwise have been missed.
Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
Limited use of genetic counselors and high rate of double mastectomy in women at average risk with early-stage breast cancer illustrate that understanding of genetic testing results is limited.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...